Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Mir-155 Enhances B-Cell Lymphoma Growth By Targeting TBRG1

Joost Kluiver, PhD, Izabella Slezak-Prochazka, PhD, Melanie Winkle, Lydia Visser, PhD, Arjan Diepstra, MD PhD, Bart-Jan Kroesen, PhD, Anke Van den Berg, PhD

Blood (2015) 126 (23): 4820.

https://doi.org/10.1182/blood.V126.23.4820.4820

Published: 2015

Journal Articles

Mutations in CD58 and Other Immune System Related Genes in Hodgkin Lymphoma

Fazlyn Reeny Abdul Razak, Arjan Diepstra, MD PhD, Lydia Visser, PhD, Anke Van den Berg, PhD

Blood (2015) 126 (23): 1439.

https://doi.org/10.1182/blood.V126.23.1439.1439

Published: 2015

Journal Articles

A Meta-Analysis Of Hodgkin Lymphoma Reveals 19p13.3 (TCF3) As a Novel Susceptibility Loc

Wendy Cozen, D.O., M.P.H., Dalin Li, M.D., Ph.D., Maria Timofeeva, Ph.D., Arjan Diepstra, MD PhD, Dennis Hazelett, Ph.D., Manon Delahaye-Sourdeix, M.S., Christopher K. Edlund, M.S., Klaus Rostgaard, Ph.D., David J. Van Den Berg, Ph.D., Lude Franke, Ph.D., Karin Eckstrom Smedby, M.D., Ph.D., Sally L. Glaser, Ph.D., Harm-Jam Westra, Ph.D., Leslie L. Robison, PhD, Thomas M. Mack, M.D., M.P.H., Herve Ghesquieres, MD, PhD, Amie E. Hwang, Ph.D., M.P.H., Alexandra Nieters, Ph.D., Silvia de Sanjosé, M.D., Ph.D., Victoria K. Cortessis, Ph.D., Tracy Lightfoot, Nikolaus Becker, M.D., Ph.D., Marc Maynadie, MD, PhD, Lenka Foretova, Ph.D., Eve Roman, Ph.D., Yolanda Benavente, Ph.D., Bharat N. Nathwani, M.D., Bengt Glimelius, M.D., Ph.D., Anthony Staines, M.D., Ph.D., Paolo Boffetta, M.D., M.P.H., Brian K Link, MD, L. A. Kiemeney, Ph.D., Stephen M Ansell, M.D.Ph.D., Smita Bhatia, Ph.D., Louise C Strong, Ph.D., Pilar Galan, M.D., Lars Vatten, M.D., Ph.D., Thomas M Habermann, MD, Eric J. Duell, Ph.D., M.S., Annette Lake, M.S., Rianne Veenstra, Lydia Visser, PhD, Kevin Urayama, Ph.D., Dorothy Montgomery, Valerie Gaborieau, Lawrence Weiss, M.D, Graham Byrnes, Ph.D., Mark Lathrop, PhD, Hans-Olov Adami, M.D., Ph.D., Mads Melbye, MD, DMSc, James R Cerhan, MD, PhD, Alice Gallagher, M.D., G. Malcolm Taylor, MD, Susan L Slager, PhD, Paul Brennan, Ph.D., David V. Conti, Ph.D., Gerhard Coetzee, Ph.D., Kenan Onel, MD, PhD, Ruth F. Jarrett, M.D., Ph.D., Henrik Hjalgrim, M.D., Ph.D., Anke Van Den Berg, PhD, James D. McKay, Ph.D.

Blood (2013) 122 (21): 626.

https://doi.org/10.1182/blood.V122.21.626.626

Published: 2013

Journal Articles

Expression, Prognostic Value and Function of IGF1R in Hodgkin Lymphoma.

Zheng Liang, MD, Arjan Diepstra, MD PhD, Chuanhui Xu, MD PhD, Gustaaf W van Imhoff, MD, PhD, Wouter J Plattel, MD, Anke Van Den Berg, PhD, Lydia Visser, PhD

Blood (2012) 120 (21): 2640.

https://doi.org/10.1182/blood.V120.21.2640.2640

Published: 2012

Journal Articles

EBV and HLA Associations In Classical Hodgkin Lymphoma Patients From Brazil

Kushi Kushekhar, Rianne Veenstra, Gabriela Gualco, Pollyanna Domeney, MD, Bouke Hepkema, PhD, Lydia Visser, PhD, Carlos E Bacchi, MD, Arjan Diepstra, MD, PhD, Anke Van Den Berg, PhD

Blood (2011) 118 (21): 4858.

https://doi.org/10.1182/blood.V118.21.4858.4858

Published: 2011

Journal Articles

Mid-Treatment Plasma Levels of Thymus Activated and Regulated Chemokine (TARC) Predict Treatment Outcome In Classical Hodgkin Lymphoma Patients

Wouter Plattel, MD, Anke Van Den Berg, PhD, Anne Marijn Van der Graaf, Hans Vos, Lydia Visser, PhD, Arjan Diepstra, MD, PhD, Gustaaf van Imhoff, MD, PhD

Blood (2010) 116 (21): 748.

https://doi.org/10.1182/blood.V116.21.748.748

Published: 2010

Journal Articles

Protective and Predisposing HLA Alleles In Dutch Classical Hodgkin Lymphoma Patients

Arjan Diepstra, MD, PhD, Xin Huang, Ilja Nolte, PhD, Bouke Hepkema, PhD, Wierd Kooistra, Lydia Visser, PhD, Sibrand Poppema, MD, PhD, Anke Van Den Berg, PhD

Blood (2010) 116 (21): 749.

https://doi.org/10.1182/blood.V116.21.749.749

Published: 2010

Journal Articles

Expression of the c-Met Oncogene Correlates with Favorable Progression Free Survival In Classical Hodgkin Lymphoma

Chuanhui Xu, Anke Van Den Berg, PhD, Wouter Plattel, drs., Nele Ruther, Huang Xin, Sr, Miao Wang, Gustaaf Van Imhoff, MD, PhD, Andreas Viardot, Peter Möller, Sibrand Poppema, MD, PhD, Lydia Visser, PhD

Blood (2010) 116 (21): 3880.

https://doi.org/10.1182/blood.V116.21.3880.3880

Published: 2010

Journal Articles

HLA Class I and EBV Positive Classical Hodgkin Lymphoma In the Chinese Population

Huang Xin, MD, Arjan Diepstra, MD, PhD, Zifen Gao, MD, PhD, Lydia Visser, PhD, Hans Vos, Wierd Kooistra, Sibrand Poppema, MD, PhD, Bouke Hepkema, PhD, Anke Van Den Berg, PhD

Blood (2010) 116 (21): 2688.

https://doi.org/10.1182/blood.V116.21.2688.2688

Published: 2010

Journal Articles

Serum TARC Levels Correspond with Tumor Load and Response to Chemotherapy in Classical Hodgkin Lymphoma Patients.

Arjan Diepstra, MD, PhD, Anne Marijn van der Graaf, Hans JTWM Vos, Lydia Visser, PhD, Anke Van Den Berg, PhD, Gustaaf van Imhoff, MD, PhD

Blood (2009) 114 (22): 3663.

https://doi.org/10.1182/blood.V114.22.3663.3663

Published: 2009

Journal Articles

CD4+CD26 - T Cell Population in Classical Hodgkin Lymphoma Displays a Distinctive Regulatory T Cell Population.

Yue Ma, Lydia Visser, PhD, Tjasso Blokzijl, Geert Harms, Cigdem Atayar, PhD, Sibrand Poppema, MD, PhD, Anke van den Berg, PhD

Blood (2007) 110 (11): 384.

https://doi.org/10.1182/blood.V110.11.384.384

Published: 2007

Journal Articles

Comparison of the ZAP70 + and ZAP70 − B-CLL Kinome: Higher Kinase Activity in ZAP70 + B-CLL Cells.

Miao Wang, MD, MSC, Stephano Rosati, MD, Kaushal Parikh, MSC, Maikel Peppelenbosch, PhD, Simon Daenen, MD,PhD, P.M. Kluin, MD, PhD, Lydia Visser, PhD

Blood (2006) 108 (11): 2804.

https://doi.org/10.1182/blood.V108.11.2804.2804

Published: 2006

Journal Articles

Discovery of Biomarkers for Hodgkin Lymphoma Using Proteomics Technology.

Yue Ma, Han Roelofsen, PhD, Lydia Visser, PhD, Marcel de Vries, Gloria Alvarez-Llamas, PhD, Hans Vos, Roel Vonk, PhD, Sibrand Poppema, MD. PhD, Anke van den Berg, PhD

Blood (2006) 108 (11): 2261.

https://doi.org/10.1182/blood.V108.11.2261.2261

Published: 2006

Journal Articles

TARC and MDC Are the Only Chemokines with Highly Increased Levels in Serum of Hodgkin Lymphoma Patients.

Marijke Niens, MSc, Lydia Visser, PhD, Ruth F. Jarrett, MD, Gerard J. te Meerman, PhD, Sibrand Poppema, MD, Anke van den Berg, PhD

Blood (2006) 108 (11): 2268.

https://doi.org/10.1182/blood.V108.11.2268.2268

Published: 2006

NARROW

Mir-155 Enhances B-Cell Lymphoma Growth By Targeting TBRG1

Mutations in CD58 and Other Immune System Related Genes in Hodgkin Lymphoma

A Meta-Analysis Of Hodgkin Lymphoma Reveals 19p13.3 (TCF3) As a Novel Susceptibility Loc

Expression, Prognostic Value and Function of IGF1R in Hodgkin Lymphoma.

EBV and HLA Associations In Classical Hodgkin Lymphoma Patients From Brazil

Mid-Treatment Plasma Levels of Thymus Activated and Regulated Chemokine (TARC) Predict Treatment Outcome In Classical Hodgkin Lymphoma Patients

Protective and Predisposing HLA Alleles In Dutch Classical Hodgkin Lymphoma Patients

Expression of the c-Met Oncogene Correlates with Favorable Progression Free Survival In Classical Hodgkin Lymphoma

HLA Class I and EBV Positive Classical Hodgkin Lymphoma In the Chinese Population

Serum TARC Levels Correspond with Tumor Load and Response to Chemotherapy in Classical Hodgkin Lymphoma Patients.

CD4+CD26 - T Cell Population in Classical Hodgkin Lymphoma Displays a Distinctive Regulatory T Cell Population.

Comparison of the ZAP70 + and ZAP70 − B-CLL Kinome: Higher Kinase Activity in ZAP70 + B-CLL Cells.

Discovery of Biomarkers for Hodgkin Lymphoma Using Proteomics Technology.

TARC and MDC Are the Only Chemokines with Highly Increased Levels in Serum of Hodgkin Lymphoma Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only